Search Results

There are 4418158 results for: content related to: Prevention of Adolescent Psychoactive Substance Use

  1. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties

    Drug Testing and Analysis

    Volume 8, Issue 8, August 2016, Pages: 768–778, Marta Rychert and Chris Wilkins

    Version of Record online : 9 FEB 2016, DOI: 10.1002/dta.1943

  2. Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 4, August 2012, Pages: 549–556, Elisabeth Frauger, Sandra Nordmann, Veronica Orleans, Vincent Pradel, Vanessa Pauly, Xavier Thirion, Joëlle Micallef and réseau des CEIPs

    Version of Record online : 12 MAY 2011, DOI: 10.1111/j.1472-8206.2011.00950.x

  3. Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′,4′-methylenedioxy-4-methylaminorex (MDMAR)

    Drug Testing and Analysis

    Volume 7, Issue 7, July 2015, Pages: 555–564, Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, Brendan Twamley, John O'Brien, Brian Talbot, Geraldine Dowling, Olivia Mahony, Simon D. Brandt, Julian Patrick, Roland P. Archer, John S. Partilla and Michael H. Baumann

    Version of Record online : 20 OCT 2014, DOI: 10.1002/dta.1732

  4. You have free access to this content
    Abstracts

    Drug and Alcohol Review

    Volume 32, Issue S1, November 2013, Pages: 2–74,

    Version of Record online : 8 NOV 2013, DOI: 10.1111/dar.12077

  5. A family study of anxiety disorders: familial transmission and relationship to mood disorder and psychoactive substance use disorder

    Acta Psychiatrica Scandinavica

    Volume 90, Issue 5, November 1994, Pages: 366–374, I. Skre, S. Onstad, J. Edvardsen, S. Torgersen and E. Kringlen

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1994.tb01608.x

  6. Psychoactive substance use in three sites in China: gender differences and related factors

    Addiction

    Volume 90, Issue 11, November 1995, Pages: 1503–1515, HAO WEI, DERSON YOUNG, LI LINGJIANG, XIAO SHUIYUAN, TU JIAN, SHEN HANSHU, YU ZHUNHONG, TENG XIOUYING and WAN XUDONG

    Version of Record online : 24 JAN 2006, DOI: 10.1046/j.1360-0443.1995.901115039.x

  7. The interim regulated legal market for NPS (‘legal high’) products in New Zealand: The impact of new retail restrictions and product licensing

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 868–875, Chris Wilkins

    Version of Record online : 12 MAY 2014, DOI: 10.1002/dta.1643

  8. Developmental Risks for Substance Use in Adolescence: Age as Risk Factor

    Clinical Handbook of Adolescent Addiction

    Manuel Lopez-Leon, Jesse A. Raley, Pages: 132–138, 2012

    Published Online : 4 DEC 2012, DOI: 10.1002/9781118340851.ch12

  9. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 832–839, Ruri Kikura-Hanajiri, Nahoko Uchiyama, Maiko Kawamura and Yukihiro Goda

    Version of Record online : 26 DEC 2013, DOI: 10.1002/dta.1584

  10. Alcohol and drugs in seriously injured drivers in six European countries

    Drug Testing and Analysis

    Volume 5, Issue 3, March 2013, Pages: 156–165, Sara-Ann Legrand, Cristina Isalberti, Trudy Van der Linden, Inger Marie Bernhoft, Tove Hels, Kirsten Wiese Simonsen, Donata Favretto, Santo Davide Ferrara, Marija Caplinskiene, Zita Minkuviene, Alvydas Pauliukevicius, Sjoerd Houwing, René Mathijssen, Pirjo Lillsunde, Kaarina Langel, Tom Blencowe and Alain G. Verstraete

    Version of Record online : 11 AUG 2012, DOI: 10.1002/dta.1393

  11. Reference materials for new psychoactive substances

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 505–514, Roland P. Archer, Ric Treble and Keith Williams

    Version of Record online : 11 JUL 2011, DOI: 10.1002/dta.317

  12. New psychoactive substances legislation in Ireland – Perspectives from academia

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 884–891, Pierce V. Kavanagh and John D. Power

    Version of Record online : 29 JAN 2014, DOI: 10.1002/dta.1598

  13. Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 295–301, Giovanni Martinotti, Matteo Lupi, Leonardo Carlucci, Eduardo Cinosi, Rita Santacroce, Tiziano Acciavatti, Eleonora Chillemi, Ludovica Bonifaci, Luigi Janiri and Massimo Di Giannantonio

    Version of Record online : 28 JUL 2015, DOI: 10.1002/hup.2486

  14. You have free access to this content
    Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill

    Addiction

    Volume 112, Issue 1, January 2017, Pages: 25–31, Peter Reuter and Bryce Pardo

    Version of Record online : 24 MAY 2016, DOI: 10.1111/add.13439

  15. Substance use and suicidal conduct: A study of adolescents hospitalized for suicide attempt and ideation

    Acta Paediatrica

    Volume 94, Issue 7, July 2005, Pages: 952–959, Marie Méan, Nadia Camparini Righini, Françoise Narring, André Jeannin and Pierre-André Michaud

    Version of Record online : 2 JAN 2007, DOI: 10.1111/j.1651-2227.2005.tb02016.x

  16. You have free access to this content
    Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for ‘low-risk’ psychoactive products in New Zealand?

    Addiction

    Volume 110, Issue 4, April 2015, Pages: 714–715, Marta Rychert and Chris Wilkins

    Version of Record online : 15 MAR 2015, DOI: 10.1111/add.12853

  17. Rethinking alcohol, tobacco and other drug control

    Addiction

    Volume 98, Issue 6, June 2003, Pages: 713–716, ROBIN ROOM

    Version of Record online : 22 MAY 2003, DOI: 10.1046/j.1360-0443.2003.00339.x

  18. Deaths of individuals aged 16–24 years in the UK after using mephedrone

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 225–232, Barbara Loi, John Martin Corkery, Hugh Claridge, Christine Goodair, Stefania Chiappini, Carla Gimeno Clemente and Fabrizio Schifano

    Version of Record online : 28 JUL 2015, DOI: 10.1002/hup.2423

  19. You have free access to this content
    The New Zealand Psychoactive Substances Act (PSA): a policy breakthrough or just a symbolic act?

    Addiction

    Volume 109, Issue 10, October 2014, Pages: 1590–1591, Anne Line Bretteville-Jensen

    Version of Record online : 27 AUG 2014, DOI: 10.1111/add.12541

  20. A systematic review of the effects of novel psychoactive substances ‘legal highs’ on people with severe mental illness

    Journal of Psychiatric and Mental Health Nursing

    Volume 23, Issue 5, June 2016, Pages: 267–281, R. Gray, D. Bressington, E. Hughes and A. Ivanecka

    Version of Record online : 1 APR 2016, DOI: 10.1111/jpm.12297